KRISTEN BOWMAN: Open Payments
NPI 1073876512 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,755 in 129 payments from 24 companies in 2025. Trend: 2023 $2,542 · 2024 $2,029 · 2025 $2,755
Food & beverage: $2,755
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $573 |
| UCB, Inc. | 23 | $458 |
| PFIZER INC. | 17 | $238 |
| Neurocrine BioSciences, Inc. | 9 | $231 |
| SK Life Science, Inc. | 8 | $158 |
| CATALYST PHARMACEUTICALS, INC. | 5 | $134 |
| ARGENX US, INC. | 5 | $121 |
| Neurelis, Inc. | 5 | $113 |
| Lilly USA, LLC | 5 | $112 |
| Alexion Pharmaceuticals, Inc. | 4 | $90 |
Products named: Briviact, QULIPTA, NURTEC ODT, INGREZZA, UBRELVY, VYVGART HYTRULO, VALTOCO, KISUNLA.
Industry payments across NV — which companies pay providers there.
